Health Ministry Dismisses ARV Shortage Claims, Assures Patients of Availability at Designated Facilities

The Ministry of Health has dismissed claims of a shortage of antiretroviral medicines (ARVs) in Ghana, assuring persons living with HIV that the life-saving medicines remain available at designated health facilities across the country.

The Ministry’s clarification follows concerns raised by the Network of Persons Living with HIV in Ghana (NAP+ Ghana) over the alleged shortage of ARVs and its potential impact on people receiving HIV treatment.

In a statement issued on Tuesday, August 11, and signed by its Spokesperson, Tony Goodman, the Ministry said it was inaccurate to suggest that antiretroviral medicines were unavailable in Ghana.

“It is not accurate that antiretroviral medicines are unavailable in the country. ARVs are available at designated health facilities across Ghana to support the continued treatment and care of persons living with HIV,” the Ministry stated.

The Ministry explained that it was implementing measures under its routine procurement and supply arrangements to maintain adequate stocks of essential medicines and prevent disruptions in treatment.

According to the Ministry, steps are also being taken to facilitate the timely distribution of medicines and other essential health commodities to health facilities across the country.

It, however, did not disclose the current national stock levels of ARVs or indicate whether some facilities may be experiencing temporary or isolated supply challenges.

Ministry denies ARVs expired at port

The Ministry also rejected claims that consignments of antiretroviral medicines had expired at the port.

It described such claims as inaccurate and said it was working with relevant stakeholders to ensure the effective management and timely clearance of medical commodities.

“The Ministry wishes to clarify that it is incorrect to suggest that antiretroviral medicines have expired at the port,” it said.

The Ministry’s response comes amid growing concerns from HIV advocacy groups about the availability and distribution of ARVs, which are essential for suppressing the HIV virus and helping people living with the condition maintain their health.

Engagement with NAP+ Ghana

The Ministry said it had engaged NAP+ Ghana following the concerns raised by the organisation and reaffirmed its willingness to work with stakeholders to address challenges relating to the availability and distribution of ARVs.

“We remain committed to constructive engagement with all stakeholders to ensure that persons living with HIV have uninterrupted access to the medicines and services they require,” the Ministry said.

It further assured persons living with HIV and the general public that it would continue to take steps to safeguard access to essential medicines and ensure the equitable distribution of ARVs.

While the Ministry maintains that ARVs are available at designated health facilities, the concerns raised by NAP+ Ghana highlight the importance of effective stock monitoring, procurement and distribution systems.

Health authorities and stakeholders will therefore be expected to continue monitoring supplies at individual facilities to identify and address any localised shortages before they disrupt treatment.

For persons living with HIV, uninterrupted access to ARVs remains critical, as interruptions in treatment can undermine effective HIV management and potentially contribute to treatment failure and drug resistance.